April 17, 2022
Neuropsychotropic Drug Therapy 2021 | Psychopharmacology for Depression During Pregnancy and Postpartum
Neuropsychotropic Drug Therapy 2021
Psychopharmacology for Depression During Pregnancy and Postpartum
Amritha Bhat, MBBS, MD, MPH, Acting Assistant Professor, Psychiatry, School of Medicine, University of Washington, Seattle
Objectives for Learning Outcomes
At the conclusion of this activity, participants will be better able to:
- Describe risks of untreated depression and anxiety during pregnancy and postpartum for mothers and children.
- Discuss recent findings regarding risks of psychotropic medications during pregnancy and postpartum.
- Discuss how recent findings affect informed consent discussions with patients.